3,3′,5-三碘-L-甲状腺素-13C6
3,3′,5-三碘-L-甲状腺素-13C6用途
3,3′,5-三碘-L-甲状腺素-13C6名称
3,3′,5-三碘-L-甲状腺素-13C6生物活性
[ 描述 ]:
[ 相关类别 ]:
[参考文献]
3,3′,5-三碘-L-甲状腺素-13C6物理化学性质
[ 分子式 ]:
13C6C9H12I3NO4
[ 分子量 ]:
656.93
[ 外观性状 ]:
liquid
3,3′,5-三碘-L-甲状腺素-13C6安全信息
[ 符号 ]:
GHS02, GHS06, GHS08
[ 信号词 ]:
Danger
[ 危害声明 ]:
H225-H301 + H311 + H331-H370
[ 警示性声明 ]:
P210-P260-P280-P301 + P310-P311
[ 危险品运输编码 ]:
UN1230 - class 3 - PG 2 - Methanol, solution
3,3′,5-三碘-L-甲状腺素-13C6文献
PLoS ONE 9(5) , e97882, (2014)
Our limited ability to assess spontaneous pain in rodent models of painful human conditions may be associated with a translational failure of promising analgesic compounds in to clinical use. If measu...
Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis.Crit. Rev. Oncol. Hematol. , doi:10.1016/j.critrevonc.2014.04.004, (2014)
Arterial thromboembolic events (ATEs) with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) have emerged as a serious concern, we perform a meta-analysis of randomiz...
Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.Strahlenther. Onkol. , (2014)
The purpose of this study was to analyze the mode of relapse patterns and survival of 209 patients with stage IVA and IVB nasopharyngeal carcinoma (NPC).A total of 209 patients who underwent magnetic ...
推荐生产厂家/供应商:
暂无推荐供应商。请联系客服获知如何成为推荐供应商。
相关化合物
[3,3′,5-三碘-L-甲状腺素-13C6]化源网提供3,3′,5-三碘-L-甲状腺素-13C6CAS号1213431-76-5,3,3′,5-三碘-L-甲状腺素-13C6MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询3,3′,5-三碘-L-甲状腺素-13C6上化源网,专业又轻松。>>电脑版:3,3′,5-三碘-L-甲状腺素-13C6
标题:1213431-76-5_3,3′,5-三碘-L-甲状腺素-13C6CAS号:1213431-76-5_3,3′,5-三碘-L-甲状腺素-13C6【结构式 性质 英文】 - 化源网 地址:https://m.chemsrc.com/mip/cas/1213431-76-5_1722080.html